News

GENESIS Tech Transfer Boost, new investment vehicle for health projects

The consultants GENESIS Biomed and FI Group have created GENESIS Tech Transfer Boosta new investment vehicle initially endowed with one million euros, which will invest in projects early stage in the field of health research.

In the words of Josep Lluis FalcoCEO of GENESIS Biomed, “With the creation of this new vehicle, we intend to invest in very early projects, even in the pre-constitutive phase, which will be spinoffs in a while and which is now when they most need an economic contribution to be able to generate value and be attractive in the future for large investors. of the sector”.

GENESIS Tech Transfer Boost will invest tickets from 25,000 to 100,000 per project, in exchange for equity in the companies already created, or in exchange for a commitment to equity in the projects that will become spin off later. This funding will be used for generate the maximum value in the invested projects, from the generation of the key proofs of concept to the protection of the results through patents, through the preparation of the business plan and the request for regional, national and international public financing. The investment focus will be very transversal, contemplating both pharma and medtechdiagnosis or digital health.

The vehicle has been created thanks to the synergy between the consultancies GENESIS Biomed and FI Group, which have been collaborating for several years with several common success stories, such as companies Corify Care, CreatSens, Cornea Project, Oxolife, Telara Pharma, Aortyx, Mowoot, ADmit Therapeutics, Endolipid Therapeutics, AptaTargets and Anais Medical, among others. In the words of Iván Ruiz, CEO of FI Group, “With this agreement we enable access to the most professional and extensive public-private financing of projects in a capital sector for the future of our economy, health research, where after what happened with COVID, it becomes even more important”.

Warning, scroll to continue reading

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *